BioHealth News

I95Business: CarrTech’s Sue Carr Invents and Innovates in BioHealth

I95Business: CarrTech’s Sue Carr Invents and Innovates in BioHealth

Read More
TIME: We Need to be Ready for Biotech’s ChatGPT Moment

TIME: We Need to be Ready for Biotech’s ChatGPT Moment

Read More
BioPharmaDive: Biotech landlord (and BHI Board Member) Joel Marcus on research clusters and the sector’s recovery

BioPharmaDive: Biotech landlord (and BHI Board Member) Joel Marcus on research clusters and the sector’s recovery

Read More
FDA establishes CDER Center for Clinical Trial Innovation (C3TI)

FDA establishes CDER Center for Clinical Trial Innovation (C3TI)

Read More
Pitchbook: 3 charts: The US has more startups than VCs can support

Pitchbook: 3 charts: The US has more startups than VCs can support

Read More
Adventist HealthCare Earns Spot on Newsweek’s Most Trustworthy Companies in America 2024 List

Adventist HealthCare Earns Spot on Newsweek’s Most Trustworthy Companies in America 2024 List

Read More
STAT: NCI director expresses optimism about next era of cancer research, despite shrinking budget and brain drain

STAT: NCI director expresses optimism about next era of cancer research, despite shrinking budget and brain drain

Read More
WaPo: Former NIH director Collins on his prostate cancer, medical research

WaPo: Former NIH director Collins on his prostate cancer, medical research

Read More
TEDCO Invests in Astek Diagnostics

TEDCO Invests in Astek Diagnostics

Read More
TEDCO Announces Federal Lab Leveraging Innovation to Products Pilot Program

TEDCO Announces Federal Lab Leveraging Innovation to Products Pilot Program

Read More
TEDCO Invests in Aloe Therapeutics

TEDCO Invests in Aloe Therapeutics

Read More
Technical.ly: How Baltimore plans to spend $70M in EDA Tech Hubs Funding

Technical.ly: How Baltimore plans to spend $70M in EDA Tech Hubs Funding

Read More
Medcura Closes $22.4 Million Financing to Accelerate Development of Surgical Hemostatic Gel and Surgical Hemostasis Portfolio

Medcura Closes $22.4 Million Financing to Accelerate Development of Surgical Hemostatic Gel and Surgical Hemostasis Portfolio

Read More
NeoImmuneTech Appoints Dr. Luke Oh, Ph.D. as New Chief Executive Officer

NeoImmuneTech Appoints Dr. Luke Oh, Ph.D. as New Chief Executive Officer

Read More
CF Foundation Provides Up to $8.5M to SpliSense to Support a Clinical Trial for a Potential Treatment for Splicing Mutations

CF Foundation Provides Up to $8.5M to SpliSense to Support a Clinical Trial for a Potential Treatment for Splicing Mutations

Read More
View All Posts